Medicare Enrolled
Dr. Jeffrey Helfenstein, M.D.
Cardiovascular Disease · Beverly Hills, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Helfenstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Helfenstein?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Helfenstein
Dr. Jeffrey Helfenstein is a cardiovascular disease specialist in Beverly Hills, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Helfenstein performed 2,922 Medicare services across 1,917 unique beneficiaries.
Between the years covered by Open Payments, Dr. Helfenstein received a total of $14,261 from 56 pharmaceutical and/or device companies across 710 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Helfenstein is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 37% volume in CA
$14,261 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,922
Medicare services
Top 37% in CA for cardiovascular disease
1,917
Unique beneficiaries
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~154 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
783 | $103 | $250 |
| Venipuncture for blood draw Insertion of a needle into a vein to collect blood samples. This procedure is performed on patients aged 3 years or older. |
488 | $15 | $45 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
367 | $11 | $90 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
311 | $135 | $325 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
255 | $153 | $950 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
223 | $178 | $700 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
101 | $73 | $175 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
98 | $34 | $50 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
92 | $72 | $75 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
33 | $45 | $120 |
| Pneumococcal vaccine, 23-valent A vaccine that protects against 23 types of pneumococcal bacteria. It is used to prevent infections caused by these bacteria. |
30 | $101 | $110 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
28 | $34 | $50 |
| New patient office visit, complex (60-74 min) | 21 | $171 | $450 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
19 | $170 | $800 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
18 | $31 | $100 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $50 | $100 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
14 | $11 | $200 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
13 | $20 | $350 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
12 | $57 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.7% high complexity
8.7% medium
82.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,261
Total received (2018-2024)
Avg $2,037/year across 7 years
Top 22% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
710
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,261 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,079
2023
$2,126
2022
$1,758
2021
$2,714
2020
$1,405
2019
$2,511
2018
$1,668
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$452
E.R. Squibb & Sons, L.L.C.
$340
PFIZER INC.
$335
Alnylam Pharmaceuticals Inc.
$97
Lexicon Pharmaceuticals, Inc.
$85
Edwards Lifesciences Corporation
$81
Amgen Inc.
$75
AstraZeneca Pharmaceuticals LP
$74
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$71
Regeneron Healthcare Solutions, Inc.
$62
Kiniksa Pharmaceuticals International, plc
$61
Merck Sharp & Dohme LLC
$58
Philips North America LLC
$51
Janssen Pharmaceuticals, Inc
$44
Novo Nordisk Inc
$40
Takeda Pharmaceuticals U.S.A., Inc.
$33
Otsuka America Pharmaceutical, Inc.
$30
Lilly USA, LLC
$25
Boston Scientific Corporation
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
Esperion Therapeutics, Inc.
$19
Top 3 companies account for 54.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,999
AstraZeneca Pharmaceuticals LP
$1,216
Amgen Inc.
$965
Novo Nordisk Inc
$925
Janssen Pharmaceuticals, Inc
$814
Boehringer Ingelheim Pharmaceuticals, Inc.
$709
PFIZER INC.
$627
Esperion Therapeutics, Inc.
$570
Amarin Pharma Inc.
$518
Regeneron Healthcare Solutions, Inc.
$500
E.R. Squibb & Sons, L.L.C.
$421
Edwards Lifesciences Corporation
$419
SANOFI-AVENTIS U.S. LLC
$399
Merck Sharp & Dohme Corporation
$370
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$339
Boston Scientific Corporation
$325
Alnylam Pharmaceuticals Inc.
$294
Gilead Sciences, Inc.
$217
AbbVie Inc.
$194
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$186
Kiniksa Pharmaceuticals, Ltd.
$172
ABBVIE INC.
$161
Lexicon Pharmaceuticals, Inc.
$157
Currax Pharmaceuticals LLC
$142
Merck Sharp & Dohme LLC
$138
Baxter Healthcare
$130
Takeda Pharmaceuticals U.S.A., Inc.
$128
Bayer HealthCare Pharmaceuticals Inc.
$117
Lilly USA, LLC
$98
Abbott Laboratories
$88
Actelion Pharmaceuticals US, Inc.
$86
ARBOR PHARMACEUTICALS, INC.
$81
Daiichi Sankyo Inc.
$77
Kiniksa Pharmaceuticals International, plc
$61
Biohaven Pharmaceutical Holding Company Ltd.
$57
Otsuka America Pharmaceutical, Inc.
$52
Philips North America LLC
$51
Impulse Dynamics (USA) Inc.
$50
Kowa Pharmaceuticals America, Inc.
$45
Aegerion Pharmaceuticals, Inc.
$43
Medtronic Vascular, Inc.
$36
Relypsa, Inc.
$34
Bayer Healthcare Pharmaceuticals Inc.
$24
GlaxoSmithKline, LLC.
$24
Allergan Inc.
$23
VIVUS LLC
$21
Arbor Pharmaceuticals, Inc.
$20
Medtronic, Inc.
$18
G Medical Diagnostic Services, Inc.
$17
Eisai Inc.
$15
Tactile Systems Technology Inc
$15
Amryt Pharma Holdings Ltd
$15
Itamar Medical Inc
$14
Kestra Medical Technology Services, Inc.
$14
EISAI INC.
$13
Medicure Pharma Inc.
$12
Top 3 companies account for 29.3% of all-time payments
Associated products mentioned in payments ›
(CM9) Amb Mon & Diag Und · AMVUTTRA · Adempas · Arcalyst · Assure WCD · BELSOMRA · BEVESPI AEROSPHERE · BREZTRI · BRILINTA · BYSTOLIC · Belviq · CAMZYOS · CHANTIX · CONFIRM RX · CONTRAVE · Cardiac Monitoring Suite · Corlanor · DUPIXENT · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMBLEM · ENTRESTO · EVENITY · EVKEEZA · Edarbi · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · FLEXITOUCH · GENERAL - VASCULAR INTERVENTION · HeartMate 3 Left Ventricular Dev · Hillrom - Cardiac Ambulatory Monitor · INJECTAFER · Inpefa · JANUVIA · JARDIANCE · JUXTAPID · JYNARQUE · Kerendia · LEQVIO · LOKELMA · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MOUNJARO · MULTAQ · MitraClip System · NEXLETOL · NEXLIZET · NURTEC ODT · ONPATTRO · OPSUMIT · OPTIMIZER · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · QSYMIA · REVEAL LINQ · Repatha · Reveal LINQ · Rybelsus · SAPIEN 3 Ultra RESILIA · SHINGRIX · STEGLATRO · SYNTHROID · Saxenda · TRADJENTA · TRINTELLIX · TRULICITY · UBRELVY · UPTRAVI · VARIVAX · VERQUVO · VYNDAMAX · VYNDAQEL · Varithena Administration Pack · Vascepa · Veltassa · WATCHMAN · WATCHMAN Access System · WatchPAT · Wegovy · XARELTO · XIFAXAN · ZEPBOUND · ZYPITAMAG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
584
Per 100K population
5.9
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.8 mi
0.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Helfenstein is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Helfenstein experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Helfenstein performed 783 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Helfenstein receive payments from pharmaceutical companies?
Yes. Dr. Helfenstein received a total of $14,261 from 56 companies across 710 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Helfenstein's costs compare to other cardiologists in Beverly Hills?
Dr. Helfenstein's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Helfenstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Beverly Hills
Browse cardiologists in Beverly Hills ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology